cyclazosin has been researched along with 5-methylurapidil in 4 studies
| Studies (cyclazosin) | Trials (cyclazosin) | Recent Studies (post-2010) (cyclazosin) | Studies (5-methylurapidil) | Trials (5-methylurapidil) | Recent Studies (post-2010) (5-methylurapidil) |
|---|---|---|---|---|---|
| 22 | 0 | 4 | 201 | 0 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
| Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
| Cerri, PS; de Arruda Camargo, GM; de Arruda Camargo, LA; Saad, WA | 1 |
| Aono, Y; Cools, AR; Koshikawa, N; Saigusa, T; Shimizu, N; Shirakawa, T; Taguchi, H; Takada, K; Takiguchi, H; Uchida, T | 1 |
1 review(s) available for cyclazosin and 5-methylurapidil
| Article | Year |
|---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
3 other study(ies) available for cyclazosin and 5-methylurapidil
| Article | Year |
|---|---|
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |
Effects of subtypes of adrenergic and angiotensinergic antagonists on the water and sodium intake induced by adrenaline injected into the paraventricular nucleus.
Topics: Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Animals; Behavior, Animal; Diuretics; Dose-Response Relationship, Drug; Drinking; Epinephrine; Feeding Behavior; Furosemide; Losartan; Male; Oligopeptides; Paraventricular Hypothalamic Nucleus; Piperazines; Quinazolines; Quinoxalines; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary | 2003 |
Simultaneous activation of the α1A-, α1B- and α1D-adrenoceptor subtypes in the nucleus accumbens reduces accumbal dopamine efflux in freely moving rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Agonists; Animals; Dopamine; Dose-Response Relationship, Drug; Male; Methoxamine; Microdialysis; Nucleus Accumbens; Piperazines; Quinazolines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1 | 2015 |